Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Draft Provider-Administered Drug Policies .

Actemra, Tofidence, Tyenne, Avtozma, Tocilizumab-anoh

Aldurazyme

Benlysta

Cerezyme

Cimzia

Elaprase

Emend, Fosaprepitant, Focinvez

 

 

Fabrazyme

Aralast NP; Glassia; Prolastin-C; Zemaira

Lumizyme

Naglazyme

Orencia

Remicade, Inflectra, Renflexis, Avsola, Infliximab

Elelyso

Soliris, Bkemv, Epysqli

Stelara, Wezlana, Selarsdi, Pyzchiva, Otulfi, Imuldosa, Yesintek, Steqeyma, Ustekinumab-aekn

Velcade, Boruzu, Bortezomib

VPRIV

Simponi ARIA

Vimizim